Lithuania vs Malta: Colon and rectum cancer screening coverage in Europe
Lithuania
57.9%
in 2024
Malta
49.4%
in 2024
Lithuania rank
6th
Malta rank
8th
Colon and rectum cancer screening coverage in Europe over time
- Lithuania
- Malta
How they compare
Lithuania currently reports 57.9% against 49.4% in Malta, a difference of 8.5%.
That makes Lithuania's figure about 1.2 times Malta's.
The two have swapped places 1 time across 7 shared years of data; in 2018 it was Malta ahead.
Lithuania ranks 6th and Malta ranks 8th of 20 countries.
Across the 2 decades both report, Lithuania averaged higher in 1 and Malta in 1.
Head to head by decade
| Decade | Lithuania | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 53.7% | 61.0% | 7.2% | Malta |
| 2020s | 53.1% | 48.3% | 4.8% | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher colon and rectum cancer screening coverage in europe, Lithuania or Malta?
- Lithuania, at 57.9% against 49.4% in Malta as of 2024.
- What is the difference in colon and rectum cancer screening coverage in europe between Lithuania and Malta?
- 8.5%, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and Malta?
- 7 years are reported by both, from 2018 to 2024.
- How do Lithuania and Malta rank globally for colon and rectum cancer screening coverage in europe?
- Lithuania ranks 6th and Malta ranks 8th of 20 countries.
- Where does this data come from?
- Eurostat (2026) – with minor processing by Our World in Data, published as Colon and rectum cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of people aged 50 to 74 years who have been screened for colon and rectum cancer within the previous 2 years.